Pasqal SAS (pending Nasdaq: BBCQ)
Full-stack quantum hardware: on-premise QPU sales/deployment + Quantum-as-a-Service (QaaS via Azure, Google Cloud, OVHcloud, Scaleway) + government/enterprise R&D grants and contracts. Pre-revenue-scale; ~100% rev growth in 2025 off a small base, funded by equity and sovereign backing.
Only the 2026 pre-listing marks are disclosed; Series A (€25M, 2021) and Series B (€100M, 2023) valuations were never disclosed and are omitted. SPAC is pro-forma/announced, not yet closed.
Earnings, margins, COGS & capex
Pasqal is an early-commercial quantum hardware company: small but ~100%-growing revenue (2025, unaudited), ~$80M of booked-and-awarded business (including grants), and a cash-burning P&L funded by equity rounds and sovereign backing. Absolute revenue, margins, and EBITDA were not disclosed in the SPAC announcement; the F-4 registration statement (when filed) is the place forward projections will appear. Treat all multi-year projections as not-yet-public.
Revenue trend
Margins
COGS structure
not disclosed — dominated by QPU hardware build (lasers, vacuum/cryo-adjacent systems, optics, controls) and skilled labor (70 of ~275 staff are PhDs).
Capex
High and rising: scaling manufacturing to 13 QPUs/year across France and a Sherbrooke, Québec (Canada) facility; 7 systems deployed, 3 in production as of Mar 2026. Absolute capex not disclosed.
Latest earnings
n/a — pre-IPO, no consensus
Long-dated projections (if any) reside in the not-yet-public SPAC investor deck / F-4; not disclosed here. Do not fabricate.
- QPUs deployed
- 7 (Mar 2026)
- QPUs in production
- 3
- Mfg capacity
- up to 13 QPU/yr (France + Canada)
- Commercial customers & partners
- 25+
- Headcount
- ~275 (70 PhDs)
- Booked & awarded business
- ~$80M (incl. grants)
Growth drivers
- On-premise QPU sales to governments, HPC centers and large enterprises (sovereign-compute demand in EU)
- QaaS distribution via Microsoft Azure Quantum (first neutral-atom QPU on Azure), Google Cloud, OVHcloud + Scaleway sovereign clouds
- Analog quantum simulation use-cases (materials, chemistry, optimization) usable today at full qubit count before fault tolerance
- Roadmap to 10,000 qubits and fault-tolerant/digital gate-based operation; logical-qubit error correction
- Government/EU grants and defense programs (BPIfrance, EIC, French Defense Innovation Fund)
Bull & bear
A differentiated, room-temperature neutral-atom architecture with real deployed systems, a Nobel-pedigree team, sovereign-European tailwinds, and a clear public-market path at a ~$2B valuation that is a fraction of the P/S multiples public quantum peers command.
- Neutral-atom is one of the leading scalable modalities: room-temperature operation (~3 kW, rack-mountable Orion) avoids dilution-fridge cost/complexity of superconducting (IonQ-trapped-ion and Rigetti/Google-superconducting); same hardware runs analog AND digital modes.
- Real commercial traction for a quantum name: 7 QPUs deployed + 3 in production, 25+ customers/partners (Sumitomo, CMA CGM, Thales, LG Electronics), ~$80M booked/awarded, ~100% 2025 revenue growth.
- Blue-chip cap table and sovereign backing: Temasek (Series B lead), Orange, BPIfrance Large Venture, EIC Fund, Quantonation, Eni Next, Wa'ed Ventures — plus French/EU strategic-autonomy demand for sovereign compute.
- Distribution moat-in-progress: first neutral-atom QPU on Microsoft Azure Quantum, also on Google Cloud, OVHcloud and Scaleway sovereign clouds — multi-cloud reach without owning the cloud.
- Valuation arbitrage vs. public peers: $2.0B pre-money / $2.6B pro forma is far below IonQ (~$19–21B on ~$65M rev) and Rigetti (~$6–7B on ~$7M rev); if neutral-atom scaling works and Pasqal re-rates to peer P/S, the de-SPAC entry looks cheap.
- Deep scientific bench: co-founder Alain Aspect (2022 Nobel), Antoine Browaeys (2025 Bell Prize); IBM Quantum Network member and NVIDIA collaborator on hybrid HPC–quantum.
A pre-scale, cash-burning quantum hardware company entering public markets through a SPAC at a frothy moment for the sector, into intensifying neutral-atom competition (QuEra/Google, Atom/Microsoft) and a fault-tolerance timeline that has slipped for the entire industry. Non-US issuer — analysis-only.
- Pre-economic-scale: absolute revenue, gross margin and EBITDA undisclosed; ~$80M is mostly booked/awarded incl. grants, not recognized revenue — real revenue is likely single/low-double-digit millions, against ongoing heavy burn.
- SPAC structure risk: de-SPACs carry redemption risk (the >$600M proceeds assume minimal redemptions), sponsor dilution, and a history of post-merger underperformance; deal not closed until H2 2026 and subject to shareholder/regulatory approval.
- Brutal competition in neutral-atom: QuEra (Google + SoftBank-backed, $230M raise, Harvard/MIT logical-qubit lead), Atom Computing (Microsoft-backed), Infleqtion (now NYSE: INFQ) — plus trapped-ion (IonQ) and superconducting (Google, IBM, Rigetti) — all chasing the same fault-tolerance prize.
- Roadmap-vs-reality gap: the industry's 'fault tolerance by 2028' and '10,000-qubit' targets have repeatedly slipped; commercial quantum advantage for revenue-bearing workloads remains unproven across all modalities.
- Sector valuation froth: public quantum pure-plays trade at extreme P/S (IonQ ~300x, Rigetti ~800x); a sector de-rating (e.g. the Jan/May 2026 selloffs) would compress Pasqal's comp-based valuation regardless of execution.
- Non-US (France) issuer with sovereign/government revenue concentration and FX exposure; per QAI policy this is analysis-only, not a buy recommendation.
What it is worth
Private mark anchored to the announced SPAC transaction, cross-checked against public quantum pure-play comps (P/S) given absolute revenue is undisclosed. Deal: $2.0B pre-money equity value, ~$2.6B pro forma cap (Bleichroeder/BBCQ, Mar 2026). Comp set: IonQ (~$19–21B on ~$65M rev ≈ 290–330x P/S; FY26 guide $225–245M), Rigetti (~$6–7B on ~$7M rev ≈ ~800x P/S), D-Wave (QBTS), plus private QuEra (~$0.75–1B+ pre-2025 $230M round) and Atom Computing. Pasqal's ~$80M booked/awarded (grant-inclusive) and ~100% 2025 growth imply recognized revenue well below the booking figure; the $2B mark sits at a large discount to IonQ/Rigetti P/S but a premium to QuEra's last private mark.
<$1B
heavy redemptions and/or a sector de-rating, slipping roadmap and competition from better-funded QuEra/Atom compress the mark well below the deal value.
~$2.0–2.6B
transaction value holds; modest re-rating as a scarce European neutral-atom pure-play with real deployments.
~$3.5–5B+
de-SPAC closes clean, revenue scales toward IonQ-style trajectory, neutral-atom wins fault-tolerance share, re-rates toward peer P/S.
Highly sensitive to (a) the de-SPAC closing with limited redemptions, (b) sector P/S staying elevated, and (c) execution on the 13-QPU/yr scale-up. Not financial advice; non-US issuer, analysis-only.
SWOT
Strengths
- Differentiated room-temperature neutral-atom hardware (analog + digital on one machine)
- Nobel-laureate scientific pedigree (Alain Aspect) and strong PhD bench (70 of ~275)
- Real deployed fleet (7 QPUs) and 25+ named enterprise/government customers
- Blue-chip, sovereign-aligned cap table (Temasek, Orange, BPIfrance, EIC)
- Multi-cloud QaaS distribution (Azure, Google Cloud, OVHcloud, Scaleway)
Weaknesses
- Pre-scale economics — small undisclosed revenue, heavy cash burn, no path-to-profit disclosed
- Reliance on grants/government in the ~$80M booked-and-awarded figure
- Capital-intensive QPU manufacturing scale-up
- Fault tolerance and digital-mode maturity still ahead, not delivered
- Non-US listing-via-SPAC with redemption and post-de-SPAC overhang risk
Opportunities
- European sovereign-compute and defense demand for non-US quantum hardware
- Hybrid HPC–quantum integration (NVIDIA collaboration; data-center on-prem sales)
- Analog quantum simulation revenue today (chemistry, materials, optimization) ahead of fault tolerance
- Re-rate toward public-peer P/S multiples if scaling executes
- Expansion of installed base via Canada (Sherbrooke) manufacturing
Threats
- QuEra (Google/SoftBank) and Atom Computing (Microsoft) out-resourcing Pasqal in the same modality
- Hyperscaler in-house quantum efforts (Google neutral-atom, IBM, AWS, Microsoft) commoditizing access
- Sector-wide valuation de-rating compressing the comp basis
- Slipping fault-tolerance timelines undermining the whole quantum-hardware thesis
- FX, EU regulatory and government-budget dependency
Moats, dependencies & bottlenecks
Moats
Differentiated room-temperature neutral-atom architecture (analog + digital on one rack-mountable ~3kW machine) Real engineering edge vs. cryogenic superconducting, but QuEra/Atom share the modality — not a sole-source moat.
Antoine Browaeys; 70 PhDs) Hard-to-replicate human capital; anchors recruiting and credibility.
13 QPU/yr) Few quantum firms ship and install at this cadence; switching cost grows with each on-prem deployment.
Orange, BPIfrance, EIC) Privileged access to EU sovereign-compute/defense budgets; a real but policy-dependent moat.
Google Cloud, OVHcloud, Scaleway) Distribution reach, but the clouds are multi-vendor and can favor rivals.
Dependencies
MKS/MKSI, specialized optics) QPU BOM depends on high-precision lasers, AOMs, vacuum/optics; supply or cost shocks hit build cadence.
Google Cloud) for QaaS reach Same partners back/build rival neutral-atom efforts; distribution leverage sits with the clouds.
EIC, Defense Innovation Fund) A large slice of ~$80M booked/awarded is grant-driven; budget cycles and policy shifts are a concentration risk.
The >$600M proceeds and public listing both hinge on a successful H2-2026 de-SPAC with limited redemptions.
Pre-profit; relies on capital markets staying open to quantum names.
Advantages
- One of the largest deployed neutral-atom fleets (7 QPUs) with real customers
- Dual analog + digital operation on the same room-temperature hardware
- Nobel-grade science team and IP
- Sovereign-European positioning into EU defense/compute budgets
- First neutral-atom QPU on Microsoft Azure Quantum (distribution first-mover)
- Going public at ~$2B — a fraction of public-peer P/S multiples
Weaknesses
- Undisclosed absolute revenue/margins; ~$80M is booked-and-awarded incl. grants, not recognized revenue
- Heavy, ongoing cash burn with no disclosed path to profitability
- Better-capitalized neutral-atom rivals (QuEra/Google, Atom/Microsoft)
- Listing via SPAC carries redemption, dilution and post-merger underperformance risk
- Government/grant revenue concentration and FX exposure
- Fault-tolerant/digital advantage still on the roadmap, not in market
Bottlenecks
- Manufacturing scale — moving from 7 deployed to 13 QPU/yr requires repeatable, yield-stable production of complex optical/vacuum systems
- Qubit fidelity & error correction — digital/fault-tolerant mode (roadmap to 10,000 qubits) not yet delivered at commercial fidelity
- Skilled-labor scarcity — quantum-hardware PhD/engineer talent is globally constrained
- Capital intensity — sustained burn before profitability; reliant on de-SPAC proceeds + future raises
- Demonstrating revenue-bearing quantum advantage to convert pilots/grants into recurring commercial revenue
Top signals & trends
Top signals
Validates a unicorn+ valuation and funds the scale-up; but de-SPAC/redemption risk caps the bull case.
Real commercial momentum for a quantum name — but absolute revenue undisclosed and grant-heavy.
Largest deployed neutral-atom fleet claim; manufacturing is a genuine differentiator vs. lab-only peers.
Multi-cloud distribution without owning a cloud.
Better-capitalized neutral-atom rivals with hyperscaler backing crowd the same modality.
Sector valuation froth + volatility threaten the comp-based mark.
More committed capital, but converts add future dilution overhang.
Strategic-autonomy tailwind in EU, but per QAI policy this is analysis-only, not a buy.
Trends
Validates Pasqal's bet; but the same trend funds QuEra/Atom.
Distribution + validation, but also commoditization and direct competition.
Structural tailwind for a French champion; policy-dependent.
Comp-based valuation is exposed to sector sentiment swings.
Open public-market access, but de-SPAC underperformance is well documented.
Near-term revenue path before fault tolerance.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
High-power/precision lasers for atom trapping and control — core BOM for neutral-atom systems.
Ultra-high-vacuum and precision-optics subsystems used across quantum hardware.
Hybrid HPC–quantum (CUDA-Q) collaborator; GPUs for classical co-processing and simulation.
Specialized optics/AOM and FPGA control-electronics vendors Acousto-optic modulators, SLMs, and FPGA controllers for atom-array addressing (specific vendors not publicly disclosed).
Japanese conglomerate — named commercial customer/partner.
Global shipping/logistics — optimization use-cases; named customer.
European defense/aerospace — named customer/partner.
Named customer/partner (materials/chemistry simulation).
HPC centers & defense agencies Sovereign-compute buyers (France/EU); grant + on-prem QPU sales.
Public trapped-ion leader; ~$19–21B market cap on ~$65M Q1-26 revenue, guiding $225–245M FY26. The quantum-pure-play valuation benchmark.
Public superconducting full-stack; ~$6–7B cap on ~$7M revenue — extreme P/S comp.
Public quantum-annealing/optimization; competes for the analog/optimization use-cases Pasqal targets today.
Private direct neutral-atom rival; $230M raise led by Google Quantum AI + SoftBank (Feb 2025), Harvard/MIT logical-qubit lead. Pasqal's most direct competitor.
Private neutral-atom rival partnered with Microsoft (Azure); nuclear-spin qubit arrays.
Neutral-atom/cold-atom; went public via SPAC (Churchill Capital Corp X) on NYSE Feb 2026 — direct listed comp.
Superconducting roadmap leader + Quantum Network (Pasqal is a member); hyperscaler-scale competitor and partner.
Superconducting (Willow) + now expanding into neutral-atom; also QuEra's backer. Hyperscaler threat.